Jie Zheng

机构：Fifth Tianjin Central Hospital, First Affiliated Hospital of Xi'an Jiaotong University · ORCID：0000-0003-4958-2091

发表论文 181 篇 · 总被引 3260 次 · h-index 35

代表论文

• LBA3 Transarterial chemoembolization (TACE) with or without lenvatinib (len) + pembrolizumab (pembro) for intermediate-stage hepatocellular carcinoma (HCC): Phase III LEAP-012 study (2024 · Annals of Oncology · 被引 32)
• Copper homeostasis and cuproptosis represent emerging targets for therapeutic intervention in inflammatory diseases (2025 · Pharmacological Research · 被引 15)
• Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study☆ (2024 · JHEP Reports · 被引 11)
• Chemokine Receptor 2 Is a Theranostic Biomarker for Abdominal Aortic Aneurysms (2025 · JACC Basic to Translational Science · 被引 9)
• Auditory Effects of Acoustic Noise From 3‐T Brain MRI in Neonates With Hearing Protection (2024 · Journal of Magnetic Resonance Imaging · 被引 6)
• Pilot first-in-human CCR2 PET/CT to detect abdominal aortic aneurysm wall instability (2025 · Theranostics · 被引 4)